Rhodes Jason P sold DYN
April 28, 2026 · Form 4 insider transaction
Rhodes Jason P sold 1 shares of Dyne Therapeutics, Inc. at $19.00 per share, a transaction worth $19.00. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1
Price
$19.00
Total value
$19.00
InsiderRhodes Jason P
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 28, 2026
Filing dateApril 30, 2026
Shares owned after8,511
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026.; The shares are held directly by AVA XI LP. AVA XI LLC is the general partner of AVA XI LP. The Reporting Person is a member of AVA XI LLC and disclaims Section 16 beneficial ownership of the securities held by AVA XI LP, except to the extent of his pecuniary interest therein, if any.